Overview
Nicholas Steier is a primary care provider, practicing in Family Medicine in Omaha, Nebraska. Dr. Steier is rated as an Experienced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, Endoscopy, and Ureteroscopy. Dr. Steier is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8613 N 30th St, Omaha, NE 68112
Lincoln Medical Education Partnership
Jeffery Hollis is a primary care provider, practicing in Family Medicine in Lincoln, Nebraska. Dr. Hollis is rated as an Advanced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. His top areas of expertise are Diabetic Neuropathy, Dehydration, Coronary Heart Disease, and Lung Metastases.
CHI Health Clinic Metabolic Health (Elkhorn)
Learn more about CHI Health's Metabolic Health program. Dr. Miller is rated as an Advanced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. Her top areas of expertise are Type B Insulin Resistance Syndrome, Abdominal Obesity Metabolic Syndrome, Mitochondrial Complex V Deficiency, and Cytochrome C Oxidase Deficiency.
Internal Medicine Physicians P.C.
David Keller is a primary care provider, practicing in Family Medicine in Omaha, Nebraska. Dr. Keller is rated as an Advanced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. His top areas of expertise are Infant Hyperglycemia, Macroamylasemia, Idiopathic Hypercalciuria, and Familial Hypocalciuric Hypercalcemia Type 1. Dr. Keller is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- BronchitisDr. Steier isAdvanced. Learn about Bronchitis.
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
- EmpyemaDr. Steier isAdvanced. Learn about Empyema.
- Familial HypertensionDr. Steier isAdvanced. Learn about Familial Hypertension.
- Gastroesophageal Reflux Disease (GERD)
- Gitelman SyndromeDr. Steier isAdvanced. Learn about Gitelman Syndrome.
- Experienced
- Acute Coronary SyndromeDr. Steier isExperienced. Learn about Acute Coronary Syndrome.
- Acute CystitisDr. Steier isExperienced. Learn about Acute Cystitis.
- Acute Kidney FailureDr. Steier isExperienced. Learn about Acute Kidney Failure.
- Acute PancreatitisDr. Steier isExperienced. Learn about Acute Pancreatitis.
- Alcoholic CirrhosisDr. Steier isExperienced. Learn about Alcoholic Cirrhosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Steier isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.